Dopaminergic agent bupropion may not improve sexual desire for female cancer survivors compared to a placebo, as per the results of the NRG Oncology CC004 clinical trial.
from Medindia Health News https://ift.tt/3m5x5eV
LATEST HEALTH NEWS
Reviewed by MZ Digital Marketing Agency
on
December 14, 2021
Rating: 5
No comments
Thanks for comment via will connect you within 24 hours.
No comments
Thanks for comment via will connect you within 24 hours.